Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis.
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseThe insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancerGenome-wide association studies in cancer--current and future directionsProgress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European AmericansVariation at 8q24 and 9p24 and risk of epithelial ovarian cancer.t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer.Synergistic effect of a combination of nanoparticulate Fe3O4 and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells.Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines.Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation.Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.Adiponectin gene and risk of colorectal cancer.Function of cancer associated genes revealed by modern univariate and multivariate association tests.MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancerXIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signallingGenome-wide association study of colorectal cancer in Hispanics.Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell linesEzrin expression and cell survival regulation in colorectal cancerPIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.Restoration of PTEN activity decreases metastases in an orthotopic model of colon cancer.Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinib.Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.Altered Adipose-Derived Stem Cell Characteristics in Macrodactyly.Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.Elucidating the role of 8q24 in colorectal cancer.Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy.Tounong Powder () extracts induce G1 cell cycle arrest and apoptosis in LoVo cells.TGFβ and IGF1R signaling activate protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells.
P2860
Q28334584-1A53EA35-109D-47D1-AF51-15916436265DQ54808689-DDF0B9E7-CBA8-48F7-ABC0-0F7C13934044Q54834763-3E1C7BDC-945C-4A05-B6C3-852021F70799Q54835723-34A1878D-4E88-4C8E-9525-4912D40C0769Q54949433-0D4920B3-67FA-4F6D-88BA-190E8D6DD2C7Q54950538-A1F59112-F019-47A0-BB57-9600E709439EQ54972066-C200715D-44D0-4C79-AF5F-B3F27F30E554Q54992758-4FF091F5-6A3E-4195-B76F-FBAE4C52DA80
P1343
Q24289344-1CB0766A-DACA-4D08-B5AC-42EAF6ED0E2DQ28266005-139D8C57-96B2-4A74-8D97-29D8E82D442CQ33814805-A9C97DE8-A8B7-4CDB-A54A-768AAF173662Q34016833-18D6CC0F-59FD-461E-89AE-D101CC26534BQ34096798-42224613-9CB5-411F-A693-7B524F9DFE09Q34099786-F6412371-C783-4B69-BDBA-50ADD58928B0Q34156895-88DFB390-BB26-4852-AF21-8B6B81DC4012Q34377965-2A0E8A4A-ED6D-42BD-9C8F-9E31F7EC6746Q34656392-468F1E11-DE29-4809-B5CA-01ABF3DABF42Q34796781-75FFD893-72FF-4F32-8F32-33F5D11B5B48Q34963434-D18C92B8-84A8-45C8-A346-51FC720940DEQ35208048-94CC88FD-C770-426D-AA05-D2D62425C367Q35628101-541902D9-D547-475C-86B1-C4CAB290E9CDQ36022236-6360BAEA-9279-4380-B8F4-5E59897834A3Q36292020-3B84E0BC-FECC-4597-820D-26E06FDB1A19Q36814884-75A8990E-A86F-448D-B2FE-4552D84EF2BFQ36927009-117212F4-5325-43E0-8368-167988B7F541Q37376993-8B762802-DBCA-4A49-9F85-B4BA8A50628BQ37682332-DA62382F-EA52-4228-95A4-995D809BAA54Q38584695-841B5F36-8B78-4BAE-A0EB-9DA77E3D83C6Q39159627-4203F1D0-2069-4D06-B9EE-8039D13DDE6DQ39354437-69C307D0-4C3D-4CB9-AE74-487BEA415AE1Q39882524-33355F4D-2B86-4501-AE82-9E87D8C04E81Q41325422-8F9C2626-48B2-4F5C-873E-1BFCC65785B7Q41998867-40F920FC-6EE7-4CE0-84CB-F80F9A1D7BB1Q46220382-D375719F-9A66-442F-A1AF-BA0331783EADQ49536215-25DE4BD4-D186-4E6B-9CDA-C3B5A84BF150Q51673030-A624AB63-9E63-4C94-BB25-848429C0EC39Q52337636-4F8C95B4-5BC3-499D-BBEE-5B2C13FE3080
P2860
Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Colon carcinoma cells harborin ...... deprivation induced apoptosis.
@en
type
label
Colon carcinoma cells harborin ...... deprivation induced apoptosis.
@en
prefLabel
Colon carcinoma cells harborin ...... deprivation induced apoptosis.
@en
P2093
P4510
P1476
Colon carcinoma cells harborin ...... deprivation induced apoptosis
@en
P2093
Alexis Conway
James K V Willson
Jennie Hauser
Julie L C Kan
Karen Kuropatwinski
Michael G Brattain
Michael R Rossi
Neil W Gibson
Yunfei Zhou
P304
P356
10.1158/1535-7163.MCT-06-0555
P577
2007-03-01T00:00:00Z